2.2(top 20%)
impact factor
7.2K(top 5%)
papers
118.9K(top 5%)
citations
97(top 5%)
h-index
2.2(top 20%)
impact factor
8.0K
all documents
125.5K
doc citations
131(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Mechanism of thrombocytopenia in COVID-19 patientsAnnals of Hematology2020404
2Epidemiology of non-Hodgkin?s lymphoma (NHL): trends, geographic distribution, and etiologyAnnals of Hematology2005403
3The IgG Fc receptor familyAnnals of Hematology1998354
4Epigenetic therapy in MDS and acute AML: focus on decitabineAnnals of Hematology2005286
5Apoptosis: mechanisms and relevance in cancerAnnals of Hematology2005274
6Blood type and outcomes in patients with COVID-19Annals of Hematology2020250
7Donor age and long-term culture affect differentiation and proliferation of human bone marrow mesenchymal stem cellsAnnals of Hematology2012239
8Antimicrobial therapy of unexplained fever in neutropenic patientsAnnals of Hematology2003233
9Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United StatesAnnals of Hematology2015219
10Von Willebrand factor: molecular size and functional activityAnnals of Hematology1996203
11Postpartum anemia I: definition, prevalence, causes, and consequencesAnnals of Hematology2011202
12Anemia—still a major health problem in many parts of the world!Annals of Hematology2011198
13Iron and pregnancy—a delicate balanceAnnals of Hematology2006197
14Mastocytosis: current concepts in diagnosis and treatmentAnnals of Hematology2002195
15A classification of acute leukaemia for the 1990sAnnals of Hematology1991190
16Cytogenetic features in myelodysplastic syndromesAnnals of Hematology2008190
17Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patientsAnnals of Hematology2010187
18Natural course and biology of CMLAnnals of Hematology2015178
19Copper deficiency anemia: review articleAnnals of Hematology2018176
20Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016Annals of Hematology2016169
21Epidemiology of chronic myeloid leukaemia: an updateAnnals of Hematology2015163
22Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)Annals of Hematology2018162
23Vitamin D deficiency and anemia: a cross-sectional studyAnnals of Hematology2010158
24Prolonged monitoring of troponin T for the detection of anthracycline cardiotoxicity in adults with hematological malignanciesAnnals of Hematology2003157
25Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemiaAnnals of Hematology2005157
26Satelite Symposium V, Meet-the-Professor Sessions I and II, Main Sessions I-IXAnnals of Hematology2004156
27Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOPAnnals of Hematology2008156
28Primary adrenal lymphoma: a systematic reviewAnnals of Hematology2013156
29Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myelomaAnnals of Hematology2000155
30Prepartum anaemia: prevention and treatmentAnnals of Hematology2008153
31The clinical importance of erythrocyte deformability, a hemorrheological parameterAnnals of Hematology1992150
32Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidaseAnnals of Hematology2003145
33Treatment of invasive fungal infections in cancer patients—updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)Annals of Hematology2014143
34Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphomaAnnals of Hematology2012142
35The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosisAnnals of Hematology2014142
36Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's diseaseAnnals of Hematology2002140
37Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patientsAnnals of Hematology2003139
38Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcomeAnnals of Hematology2007137
39Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOPAnnals of Hematology2004136
40Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphomaAnnals of Hematology1994135
41Beneficial and ominous aspects of the pleiotropic action of erythropoietinAnnals of Hematology2004134
42Efficacy and tolerability of hydroxyurea in the treatment of the hyperproliferative manifestations of myelofibrosis: results in 40 patientsAnnals of Hematology2010134
43A review of the European LeukemiaNet recommendations for the management of CMLAnnals of Hematology2015134
44Iron status in 268 Danish women aged 18-30 years: influence of menstruation, contraceptive method, and iron supplementationAnnals of Hematology1998133
45Hematological findings in coronavirus disease 2019: indications of progression of diseaseAnnals of Hematology2020132
46RNA interference (RNAi) in hematologyAnnals of Hematology2004131
47The G8 screening tool detects relevant geriatric impairments and predicts survival in elderly patients with a haematological malignancyAnnals of Hematology2014131
48Mesenchymal progenitor cells in the human umbilical cordAnnals of Hematology2004130
49Erythropoiesis-stimulating agents in the treatment of anemia in myelodysplastic syndromes: a meta-analysisAnnals of Hematology2008130
50Clinical significance of metabolic tumor volume by PET/CT in stages II and III of diffuse large B cell lymphoma without extranodal site involvementAnnals of Hematology2012130